Document is current
Any future updates will be listed below
-
Authors
Rohde, Anna M. http://orcid.org/0000-0002-2190-8267
Zweigner, Janine
Wiese-Posselt, Miriam
Schwab, Frank
Behnke, Michael
Kola, Axel
Obermann, Birgit
Knobloch, Johannes K.-M.
Feihl, Susanne
Querbach, Christiane
Gebhardt, Friedemann
Mischnik, Alexander
Ihle, Vera
Schröder, Wiebke
Armean, Sabina
Peter, Silke
Tacconelli, Evelina
Hamprecht, Axel
Seifert, Harald
Vehreschild, Maria J. G. T.
Kern, Winfried V.
Gastmeier, Petra
,
Buhl, Michael
Busch, Dirk
Eisenbeis, Simone
Först, Gesche
Foschi, Federico
Gillis, Meyke
Hansen, Dorothea
Häcker, Georg
Heim, Markus
Hug, Martin
Kaier, Klaus
Küpper, Fabian
Langebartels, Georg
Liekweg, Andrea
Lipp, Hans-Peter
Märtin, Nayana
Nordmann, Mathias
Pelzer, Andrea
Peña-Diaz, Luis-Alberto
Rupp, Jan
Schröder, Christin
Spohn, Katrin
Steib-Bauert, Michaela
Vehreschild, Jörg J.
vor dem Esche, Ulrich
Wolke, Solvy
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Infektionsforschung (TTU08.801)
- License Information
-
More Information
Article History
Received: 14 September 2018
Accepted: 11 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: The ethics committee at Charité, University Medicine Berlin, Germany, approved this study (EA/018/14). Surveillance was performed in accordance with the German Infection Protection Act and did not require patient consent.(9).
: Not applicable.
: No competing interests unless stated.MJGTV is a consultant to: Alb Fils Kliniken, Astellas Pharma, MaaT Pharma, MSD/Merck; has served with the speakers’ bureau of: Astellas Pharma, Basilea, Gilead Sciences, Merck/MSD, Organobalance and Pfizer; received research funding from: 3 M, Astellas Pharma, DaVolterra, Gilead Sciences, Merck/MSD, Morphochem, Organobalance, and Seres Therapeutics.HS reports grants from Bundesministerium für Bildung und Forschung (BMBF), the German Center for Infection Research (DZIF), Cubist, and Novartis, and personal fees from Astellas-Basilea, Cubist, Durata, Genentech, Gilead, MSD, Roche Pharma, and Tetraphase.JKMK received research and travel grants from Novartis, bioMérieux, Bayer Vital, and Alere and served as consultant or speaker for bioMérieux, Novartis,and Pfizer.JZ received a speaker’s honorarium from Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
